Does semaglutide improve clinical outcomes compared to tirzepatide in patients with obesity and HFpEF?
Real-world data suggests comparable clinical outcomes between semaglutide and tirzepatide in patients with obesity and HFpEF.
In this real-world analysis, no difference was observed between semaglutide and tirzepatide in terms of clinical outcomes among patients with obesity and HFpEF.
Monzo et al. (Wed,) studied this question.